Optune Lua adoption lag hit shares, but 2026 catalysts and $230M net cash could drive a rebound. Know more about NVCR stock ...

Step up shredberg, a Nintendo speedrunner with a particular soft spot for Super Meat Boy, who livestreamed his deathless ...

Justin McDaniel has developed a cult following for getting his students to read — as long as they follow his rules.

Independent clips echo the same story, with one widely shared reel describing the Semi’s “incredible 1.2MW charging speed” ...

In 2024, Daly, now 24, began working with Ireland’s Eye on the knitwear factory floor. He is now an assistant designer and ...

Barron’s consistently favored equities over bonds for income in the past decade, and we’re sticking with that bias in the new ...

If you’re looking at the 2025 Leapmotor C10 REEV as a potential entry point into the range-extended electric vehicle SUV ...

Sleek hatchbacks make more sense than bulky SUVs when it comes to EV efficiency. Kia’s EV4 is the new boy, and we’ve pitted ...

Invesco Emerging Markets ex-China Fund (GTDDX) had a positive return for the quarter but underperformed the MSCI EM ex China ...

Hydrogen, the lightest element on the periodic table, is a master of escaping almost any container it's stored in. Its ...

Lucara Diamond Corp. ("Lucara" or the "Company") is pleased to announce the results of an updated technical report (the "Report") for the updated Feasibility Study ("FS" or "Study"), prepared in ...

Incyte today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19 ...